Patent Issued for Ophthalmic drug sustained release formulation and uses thereof (USPTO 11324693)

Source :: Medical Devices & Surgical Technology Week. June 5, 2022, 1252
Publication Year :: 2022
Abstract: 2022 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, [...]

Subjects :: Medical equipment -- Intellectual property
Ophthalmic drugs -- Intellectual property
Fluocinolone acetonide
Nepafenac
Difluprednate
Fluocinolone
Physiological apparatus -- Intellectual property
Bromfenac -- Intellectual property
Health
Health care industry

Tools